Please login to the form below

Not currently logged in

Asana appoints new chief medical officer

Louis Denis joins from Boehringer Ingelheim

Asana Biosciences has appointed Louis Denis as its new chief medical officer.

Denis is a medical oncologist with over 20 years of academic and industry experience in clinical cancer drug development.

He will be responsible for the overall strategic direction and medical oversight of clinical development of Asana's novel product candidates.

He said: “I am delighted to join Asana at this transformative time for the company.

“I look forward to working with the Asana team and its scientific advisory board to advance the company's broad portfolio of differentiated targeted therapies to help address major unmet medical needs.”

Denis has formerly held strategic and leadership positions at Boehringer-Ingelheim, where he headed the medical team, and Pfizer. 

Sandeep Gupta, president and chief executive officer of Asana Biosciences, said: “We are extremely pleased with the addition of Dr. Denis, a highly experienced physician and scientist, to our team. It represents a significant step in our evolution as an oncology-focused clinical development company.”

29th October 2015

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....